Andesa Financial Management Inc. Vertex Pharmaceuticals Inc Transaction History

Andesa Financial Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $64,010 - $72,011	-224 Reduced 15.32%	1,238 $357,000
Q3 2022 Nov 03, 2022	BUY	$273.83 - $305.53 $44,634 - $49,801	163 Added 12.55%	1,462 $421,000
Q2 2022 Jul 27, 2022	SELL	$234.96 - $292.55 $120,299 - $149,785	-512 Reduced 28.27%	1,299 $366,000
Q1 2022 May 09, 2022	BUY	$221.42 - $260.97 $40,077 - $47,235	181 Added 11.1%	1,811 $471,000
Q4 2021 Jan 27, 2022	BUY	$177.01 - $223.45 $59,829 - $75,526	338 Added 26.16%	1,630 $358,000
Q3 2021 Oct 13, 2021	BUY	$181.39 - $202.99 $234,355 - $262,263	1,292 New	1,292 $234,000

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Andesa Financial Management Inc., based on Form 13F filings with the SEC.

Stay updated on Andesa Financial Management Inc. with notifications on news.